Compounds > nitrosobis(2-oxopropyl)amine
Page last updated: 2024-08-23

nitrosobis(2-oxopropyl)amine and dinoprostone

nitrosobis(2-oxopropyl)amine has been researched along with dinoprostone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appel, MJ; Woutersen, RA1
Ito, M; Kawarada, Y; Matsuda, S; Niimi, R; Ogura, Y; Sumitomo, M1
Fukuda, K; Kanematsu, T; Kitajima, T; Kitazato, A; Kuroki, T; Onizuka, S; Tajima, Y; Tsuneoka, N1
Crooks, PA; Holcomb, B; Neelakantan, S; Njoku, V; Ralstin, M; Schmidt, CM; Sweeney, CJ; Wu, H; Yip-Schneider, MT1
Badve, S; Gage, EA; Saxena, R; Schmidt, CM; Wentz, SC; Yip-Schneider, MT1

Other Studies

5 other study(ies) available for nitrosobis(2-oxopropyl)amine and dinoprostone

ArticleYear
Effects of dietary fish oil (MaxEPA) on N-nitrosobis(2-oxopropyl)amine (BOP)-induced pancreatic carcinogenesis in hamsters.
    Cancer letters, 1995, Aug-01, Volume: 94, Issue:2

    Topics: Animals; Arachidonic Acid; Carcinogens; Cell Division; Cricetinae; Dinoprostone; Fish Oils; Linoleic Acid; Linoleic Acids; Male; Mesocricetus; Nitrosamines; Pancreatic Neoplasms

1995
Chemoprevention of biliary carcinogenesis in syrian hamsters by the novel carboxamide derivative IS-741 after initiation with N-nitrosobis(2-oxopropyl)amine (BOP).
    Carcinogenesis, 2000, Volume: 21, Issue:8

    Topics: 6-Ketoprostaglandin F1 alpha; Adenocarcinoma; Animals; Anticarcinogenic Agents; Biliary Tract; Biliary Tract Neoplasms; Carcinogens; Choledochostomy; Common Bile Duct; Cricetinae; Dinoprostone; Enzyme Inhibitors; Female; Liver; Mesocricetus; Neutrophil Infiltration; Nitrosamines; Peroxidase; Phospholipases A; Proliferating Cell Nuclear Antigen; Pyridines; Thromboxane B2

2000
Chemopreventative effect of a cyclooxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamsters.
    Carcinogenesis, 2005, Volume: 26, Issue:2

    Topics: Animals; Biliary Tract Neoplasms; Carcinoma; Choledochostomy; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Etodolac; Female; Liver; Mesocricetus; Nitrosamines; Pancreas; Prostaglandin-Endoperoxide Synthases

2005
Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer.
    Pancreas, 2008, Volume: 37, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cell Proliferation; Chemokines, C; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Female; Ki-67 Antigen; Mesocricetus; Mucins; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Nitrosamines; Pancreatic Neoplasms; Pyrazoles; Sesquiterpenes; Sulfonamides; Time Factors

2008
Sulindac prevents carcinogen-induced intrahepatic cholangiocarcinoma formation in vivo.
    The Journal of surgical research, 2009, Volume: 157, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts; Bile Ducts, Intrahepatic; Carcinogens; Cell Division; Cholangiocarcinoma; Cricetinae; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Female; I-kappa B Proteins; Mesocricetus; NF-KappaB Inhibitor alpha; Nitrosamines; Sulindac; Transcription Factor RelA

2009